跳至主要内容
临床试验/EUCTR2011-005518-12-IT
EUCTR2011-005518-12-IT进行中(未招募)不适用

effect of oral administration of red clover on menopausal symptoms of the syndrome induced by adjuvant hormonal treatment in women diagnosed with breast cancer

AMED SR0 个研究点开始时间: 2012年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Patients who have undergone surgery for breast cancer: he chose
  • - T1-2N0-1M0 treated with tamoxifen more or less the same, more or less pre-operative adjuvant chemotherapy or
  • - Patients who are premenopausal at the time of histological diagnosis
  • - No cancer arising in pregnancy
  • - Renal function, normal cardiac and respiratory
  • - Complete blood count to normal
  • - Adherence to the study with informed consent
  • - People can take part in the study for the expected time
  • - Score rating scale (MRS Menopausal Rating Scale) = 8
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Score rating scale (MRS Menopausal Rating Scale) = 8
  • - Women after natural menopause or induced at the time of surgery
  • - A history of or concurrence of other primary malignancies except carcinoma in situ of the cervix and basal-cell carcinoma of the skin
  • - Recurrence of breast cancer
  • - Presence of distant metastases
  • - Histology different from breast cancer epithelial
  • - Lobular carcinoma in situ of the breast
  • - Participating in other clinical trials, controlled trials that could interfere with the evaluation of the results of this study
  • - Geographical inaccessibility

研究者

发起方
AMED SR

相似试验